Cargando…

Literature Overview of the Relation Between Psoriasis and Alzheimer [Corrigendum]

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676098/ https://www.ncbi.nlm.nih.gov/pubmed/38029044 http://dx.doi.org/10.2147/NDT.S449767

Ejemplares similares

Literature Overview of the Relation Between Psoriasis and Alzheimer
por: Yang, Qian, et al.
Publicado: (2023)

Distal Extension Denture – Case Report and Overview [Corrigendum]
Publicado: (2021)

Corrigendum to: Development of bispecific antibodies in China: overview and prospects
por: Zhang, Jing, et al.
Publicado: (2022)

Epigenetic mechanisms in Alzheimer’s disease [Corrigendum]
Publicado: (2014)

Biologics in Psoriasis: Updated Perspectives on Long-Term Safety and Risk Management [Corrigendum]
Publicado: (2022)

Successful strategies in implementing a multidisciplinary team working in the care of patients with cancer: an overview and synthesis of the available literature [Corrigendum
Publicado: (2018)

Speech and orofacial apraxias in Alzheimer's disease – CORRIGENDUM
por: Cera, Maysa Luchesi, et al.
Publicado: (2013)

Chronic tonsillitis and biofilms: a brief overview of treatment modalities [Corrigendum]
Publicado: (2018)

Annual biologic treatment cost for new and existing patients with moderate to severe plaque psoriasis in Greece [Corrigendum]
Publicado: (2015)

Overexpression of Lin28a Aggravates Psoriasis-Like Phenotype by Regulating the Proliferation and Differentiation of Keratinocytes [Corrigendum]
Publicado: (2021)

Effect modification, interaction and mediation: an overview of theoretical insights for clinical investigators [Corrigendum]
Publicado: (2018)

Corrigendum to “Impact and Challenges of Mesenchymal Stem Cells in Medicine: An Overview of the Current Knowledge”
por: Menaa, Farid, et al.
Publicado: (2019)

Effect modification, interaction and mediation: an overview of theoretical insights for clinical investigators [Corrigendum]
Publicado: (2019)

Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives [Corrigendum]
Publicado: (2021)

Profile of gantenerumab and its potential in the treatment of Alzheimer’s disease [Corrigendum]
Publicado: (2014)

Corrigendum to “Slower Dynamics and Aged Mitochondria in Sporadic Alzheimer's Disease”
por: Martín-Maestro, Patricia, et al.
Publicado: (2021)

Corrigendum: Involvement of insulin receptor substrates in cognitive impairment and Alzheimer’s disease
Publicado: (2019)

Corrigendum: Comparing progression biomarkers in clinical trials of early Alzheimer’s disease
Publicado: (2021)

Itolizumab – a humanized anti-CD6 monoclonal antibody with better side effects profile for the treatment of psoriasis [Corrigendum]
Publicado: (2015)

Corrigendum to: ATRI EDC: a novel cloud-native remote data capture system for large multicenter Alzheimer’s disease and Alzheimer’s disease-related dementias clinical trials
por: Jimenez-Maggiora, Gustavo A, et al.
Publicado: (2022)

Corrigendum to: Global overview of the management of acute cholecystitis during the COVID-19 pandemic (CHOLECOVID study)
Publicado: (2022)

Emerging treatment options for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis: evaluating bimekizumab and its therapeutic potential [Corrigendum]
Publicado: (2019)

Corrigendum to: Safety of ixekizumab in adult patients with plaque psoriasis, psoriatic arthritis and axial spondyloarthritis: data from 21 clinical trials
por: Genovese, Mark C, et al.
Publicado: (2021)

Corrigendum to “MUTYH Actively Contributes to Microglial Activation and Impaired Neurogenesis in the Pathogenesis of Alzheimer's Disease”
por: Mizuno, Yuri, et al.
Publicado: (2023)

Corrigendum to: the SNPcurator: literature mining of enriched SNP-disease associations
por: Tawfik, Noha S, et al.
Publicado: (2021)

Corrigendum to: “Probabilistic Distances Between Trees”
Publicado: (2018)

Effects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer’s disease [Corrigendum]
Publicado: (2014)

Serum miR-128 Serves as a Potential Diagnostic Biomarker for Alzheimer’s Disease [Corrigendum]
Publicado: (2021)

The role of taxanes in triple-negative breast cancer: literature review [Corrigendum]
Publicado: (2015)

Corrigendum to “Umbilical Cord Hematoma: A Case Report and Review of the Literature”
por: Scutiero, Gennaro, et al.
Publicado: (2018)

Corrigendum to “Maintenance of mitochondrial homeostasis for Alzheimer's disease: Strategies and challenges” [Redox Biol. 63 (2023) 102734]
por: Han, Ying, et al.
Publicado: (2023)

Quality of Evidence Supporting the Role of Tripterygium Glycosides for the Treatment of Diabetic Kidney Disease: An Overview of Systematic Reviews and Meta-Analyses [Corrigendum]
Publicado: (2022)

Primary neuroendocrine breast carcinomas: a retrospective analysis and review of literature [Corrigendum]
Publicado: (2017)

Corrigendum to “Open Periprosthetic Knee Fracture: A Case Report and Review of the Literature”
Publicado: (2020)

Corrigendum to “Contribution of Neurons and Glial Cells to Complement-Mediated Synapse Removal during Development, Aging and in Alzheimer's Disease”
por: Luchena, Celia, et al.
Publicado: (2019)

Corrigendum: Kounis syndrome induced by oral intake of aspirin: case report and literature review
por: Hangouche, Abdelkader Jalil El, et al.
Publicado: (2019)

Corrigendum to: Obturator hernia: a delayed diagnosis. A case report with literature review
por: Siddiqui, Zohaib, et al.
Publicado: (2021)

A Literature Review on the Impact of Wildfires on Emergency Departments: Enhancing Disaster Preparedness – CORRIGENDUM
por: Skinner, Richard, et al.
Publicado: (2022)

Relative nutritional deficiencies associated with centrally acting monoamines [Corrigendum]
Publicado: (2015)

Corrigendum to “Nutritional Risk Factors for Age-Related Macular Degeneration”
por: Ersoy, Lebriz, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_n20a1rngpqairukmfrqcfnd6al